title: Methylerythritol phosphate pathway to isoprenoids: kinetic modeling and in silico enzyme inhibitions in Plasmodium falciparum.
abstract: The methylerythritol phosphate (MEP) pathway of Plasmodium falciparum (P. falciparum) has become an attractive target for anti-malarial drug discovery. This study describes a kinetic model of this pathway, its use in validating 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXR) as drug target from the systemic perspective, and additional target identification, using metabolic control analysis and in silico inhibition studies. In addition to DXR, 1-deoxy-d-xylulose 5-phosphate synthase (DXS) can be targeted because it is the first enzyme of the pathway and has the highest flux control coefficient followed by that of DXR. In silico inhibition of both enzymes caused large decrement in the pathway flux. An added advantage of targeting DXS is its influence on vitamin B1 and B6 biosynthesis. Two more potential targets, 2-C-methyl-d-erythritol 2,4-cyclodiphosphate synthase and 1-hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate synthase, were also identified. Their inhibition caused large accumulation of their substrates causing instability of the system. This study demonstrates that both types of enzyme targets, one acting via flux reduction and the other by metabolite accumulation, exist in P. falciparum MEP pathway. These groups of targets can be exploited for independent anti-malarial drugs.
authors.affiliation: School of Computational & Integrative Sciences, Jawaharlal Nehru University, New Delhi, India. viveksingh.nov@gmail.com
authors.forename: Vivek Kumar
authors.initials: VK
authors.lastname: Singh
authors.forename: Indira
authors.initials: I
authors.lastname: Ghosh
mesh_terms: D019747:Aldose-Ketose Isomerases / Q000037:antagonists & inhibitors / Q000737:chemistry; D000465:Algorithms; D053898:Biosynthetic Pathways; D003198:Computer Simulation; D004791:Enzyme Inhibitors / Q000737:chemistry; D004798:Enzymes / Q000737:chemistry; D004896:Erythritol / Q000031:analogs & derivatives* / Q000378:metabolism; D004926:Escherichia coli / Q000201:enzymology; D029968:Escherichia coli Proteins / Q000037:antagonists & inhibitors / Q000737:chemistry; D007700:Kinetics; D008954:Models, Biological; D008956:Models, Chemical; D009097:Multienzyme Complexes / Q000037:antagonists & inhibitors / Q000737:chemistry; D010088:Oxidoreductases / Q000037:antagonists & inhibitors / Q000737:chemistry; D019761:Phosphorus-Oxygen Lyases / Q000037:antagonists & inhibitors / Q000737:chemistry; D017853:Phosphotransferases (Alcohol Group Acceptor) / Q000037:antagonists & inhibitors / Q000737:chemistry; D010963:Plasmodium falciparum / Q000201:enzymology* / Q000378:metabolism; D015800:Protozoan Proteins / Q000737:chemistry; D013729:Terpenes / Q000378:metabolism*; D014166:Transferases / Q000037:antagonists & inhibitors / Q000737:chemistry
chemical_list: D004791:Enzyme Inhibitors; D004798:Enzymes; D029968:Escherichia coli Proteins; D009097:Multienzyme Complexes; D015800:Protozoan Proteins; D013729:Terpenes; C421242:hydroxymethylbutenyl 4-diphosphate synthase; C443879:methyl-D-erythritol 2,4-cyclodiphosphate; D010088:Oxidoreductases; C109866:ispH protein, E coli; C522017:IspD protein, E coli; D014166:Transferases; C109461:deoxyxylulose-5-phosphate synthase; D017853:Phosphotransferases (Alcohol Group Acceptor); C404502:IspE protein, E coli; D019761:Phosphorus-Oxygen Lyases; D019747:Aldose-Ketose Isomerases; D004896:Erythritol
keywords: 1-deoxy-d-xylulose 5-phosphate; 1-deoxy-d-xylulose 5-phosphate reductoisomerase; 1-deoxy-d-xylulose 5-phosphate synthase; 1-hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate; 1-hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate reductase; 1-hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate synthase; 2-C-methyl-d-erythritol 2,4-cyclodiphosphate; 2-C-methyl-d-erythritol 2,4-cyclodiphosphate synthase; 2-phospho-4-(cytidine 5′-diphospho)-2-C-methyl-d-erythritol; 4-(cytidine 5′-diphospho)-2-C-methyl-d-erythritol; 4-(cytidine 5′-diphospho)-2-C-methyl-d-erythritol kinase; 4-(cytidine 5′-diphospho)-2-C-methyl-d-erythritol synthase; BLAST; BLAST-P; CCC; CDPME; CDPMEK; CDPMEP; CDPMES; DMAPP; DXP; DXR; DXS; Drug target; FCC; GAP; HMBPP; HMBPPR; HMBPPS; IPP; Isopentenyl pyrophosphate; Kinetic model; MECPP; MECPPS; MEP; Malaria; Metabolic control analysis; Methylerythritol phosphate (MEP); PDB; PSI-BLAST; PYR; SBML; basic local alignment search tool; concentration control coefficient; dimethylallyl diphosphate; flux control coefficient; glyceraldehyde 3-phosphate; methylerythritol phosphate; position-specific iterated BLAST; protein BLAST; protein data bank; pyruvate; system biology markup language